Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9486149 | 0.73 | EPAS1 (0.47) | EPAS1 | |
| SCHEMBL8369208 | 0.73 | EPAS1 (0.35) | EPAS1 | |
| Hydrochloric Acid SCHEMBL5846893 | 0.71 | EPAS1 (0.37) | EPAS1 | |
| SCHEMBL12822142 | 0.71 | EPAS1 (0.37) | EPAS1 | |
| SCHEMBL4453984 | 0.71 | EPAS1 (0.37) | EPAS1 | |
| SCHEMBL6253007 | 0.71 | — | — | |
| Methyl Alcohol SCHEMBL6287080 | 0.71 | EPAS1 (0.34) | EPAS1 | |
| Chloromethane SCHEMBL8155679 | 0.71 | EPAS1 (0.34) | EPAS1 | |
| SCHEMBL7552629 | 0.71 | EPAS1 (0.34) | EPAS1 | |
| SCHEMBL6252392 | 0.71 | EPAS1 (0.34) | EPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252895-A1 | Metallocene compounds and use thereof in catalysts for the polymerization of olefins | BASELL TECHNOLOGY COMPANY B.V. | 2006-11-09 | — | — | US | disclosed |
| US-7094847-B2 | Metallocene compounds and use thereof in catalysts for the polymerization of olefins | BASELL TECHNOLOGY COMPANY B.V. (NL) | 2006-08-22 | — | — | US | disclosed |
| EP-0702687-B1 | METALLOCENE COMPOUNDS AND USE THEREOF IN CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | BASELL TECHNOLOGY CO BV (NL) | 2001-12-05 | — | — | EP | disclosed |
| US-20010012877-A1 | Metallocene compounds and use thereof in catalysts for the polymerization of olefins | MONTELL TECHNOLOGY COMPANY B.V. | 2001-08-09 | — | — | US | disclosed |
| US-6211108-B1 | Metallocene compounds and use thereof in catalysts for the polymerization of olefins | MONTELL TECHNOLOGY COMPANY BV (NL) | 2001-04-03 | — | — | US | disclosed |
| EP-0702687-A1 | METALLOCENE COMPOUNDS AND USE THEREOF IN CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montell Technology Company bv (NL) | 1996-03-27 | — | — | EP | disclosed |
| WO-1995027717-A1 | METALLOCENE COMPOUNDS AND USE THEREOF IN CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | MONTELL TECHNOLOGY COMPANY BV (NL) | 1995-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252895-A1 | Metallocene compounds and use thereof in catalysts for the polymerization of olefins | CPNE4, OR10J3, ORC3 | EPAS1 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.